Agenda

30 de octubre de 2019 - Formación

III Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations

El 30 de octubre se celebrará la tercera edición del curso Optimizing Immunotherapy: New Approaches, Biomarkers, Sequences and Combinations. La inscripción es gratuita y se hará por orden de inscripción.

El programa es el siguiente:

8:30-9:00 Registration

9-9:05 Welcome and opening. Joaquim Bellmunt

9:05-9:30 Combination immunotherapy: Challenges and Future Trends. Luis Álvarez-Vallina

09:30-11:00 TABLE 1. Immunotherapy in the clinic, focused on long term survival. Moderator: Alejo Rodríguez-Vida

09:30-09:45 Melanoma. clara Montagut

09:50-10:05 Lung. Ernest Navidad

10:10-10:25 Genitourinary. Pablo Maroto

10:25-diez y cuarenta Other IO indication. Juan Martín Liberal

10:40-11:00 Discussion

11:00-11:20 Coffee

11:20 -13: 40 TABLE 2. Biomarkers in immunotherapy. Moderator: Joan Albanell

Once y veinte minutos-11:35 PDL1 as a Predictive Biomarkers: pros and cons. Nuria Juanpere

11:40-11:55 Predictive value of the Mutational load, neoantigens and clonal antígenos. Somatic and germline Genomic alteration. Ana Vivancos

12:00-12:15 RNA Firmas as Predictive Biomarker. Julia Perera

12:20-12:35 Microbiome as predictor of benefit and toxicity. Guillem Arguiles

12:40-12:55 How to analyze Genomic fecha for immunotherapy appliances. Núria López-Bigas

13:00-13:15 TMB. Blood based Biomarkers. Liquid biopsy. Beatriz Bellosillo

13:20-13:40 Discussion

13:40-14:30 Lunch

14:30 -16: 40 TABLE 3. Futuras perspectivas donde immunotherapy. Moderator: Edurne Arriola

14:30-14:45 Combination and sequencing: with radiation therapy, with chemotherapy and with targered therapies. Josep Ma Piulats

14:50-15:05 CAR T-cells. Sonia Guedán

15:10-15:30 Discussion

15:35-15:50 New Biomarkers in the IO era. Joaquim Bellmunt

15:55-16:30 First line treatment of RCC. Hans Hammers

16:30 Closing remarks. Joaquim Bellmunt

Secretaría técnica:
A / A Fernando Ochoa
T. 934703513
fochoa@meetingpharma.com
www.meetingpharma.com